Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J-P Vinel

Showing results (81-90 of 107) with videos related to

Pageof 11
Sort By:
Transplantation Proceedings|April 1, 1995
Intrahepatic portocaval shunt in patients waiting for transplantationB Suc, J P Vinel, H Rousseau, et al.
Journal of Hepatology|August 1, 1993
Hemodynamic and pharmacokinetic study of tertatolol in patients with alcoholic cirrhosis and portal hypertensionP Calès, H Caillau, O Crambes, et al.
Hepatology (Baltimore, Md.)|June 1, 1991
Systemic and splanchnic hemodynamic effects of molsidomine in rats with carbon tetrachloride-induced cirrhosisH Desmorat, J P Vinel, O Lahlou, et al.
Gastroenterology|May 1, 1992
Propranolol reduces the rebleeding rate during endoscopic sclerotherapy before variceal obliterationJ P Vinel, H Lamouliatte, P Cales, et al.
Gastroenterologie Clinique Et Biologique|June 1, 1987
[Primary biliary cirrhosis associated with autoimmune thrombopenic purpura and pleuropericarditis]P Calès, J P Vinel, J J Voigt, et al.
Gastroenterologie Clinique Et Biologique|June 29, 1999
[Treatment by porto-systemic intrahepatic shunt for refractory hydrothorax during cirrhosis]J M Péron, E Dupuis, L Alric, et al.
Hepatology (Baltimore, Md.)|October 26, 1999
Transjugular intrahepatic portosystemic shunt in the treatment of refractory bleeding from ruptured gastric varicesK Barange, J M Péron, K Imani, et al.
Gut|April 1, 1993
Diffuse vascular ectasia of the antrum, duodenum, and jejunum in a patient with nodular regenerative hyperplasia. Lack of response to portosystemic shunt or gastrectomyP Calès, J J Voigt, J L Payen, et al.
Journal of Medical Virology|March 13, 1998
Baseline level and early suppression of serum HCV RNA for predicting sustained complete response to alpha-interferon therapyJ Izopet, J L Payen, L Alric, et al.
Tissue Antigens|October 6, 2000
Study of host- and virus-related factors associated with spontaneous hepatitis C virus clearanceL Alric, M Fort, J Izopet, et al.
Pageof 11

Showing results (81-90 of 107) with videos related to

Sort By:
Pageof 11
Transplantation Proceedings|April 1, 1995
Intrahepatic portocaval shunt in patients waiting for transplantationB Suc, J P Vinel, H Rousseau, et al.
Journal of Hepatology|August 1, 1993
Hemodynamic and pharmacokinetic study of tertatolol in patients with alcoholic cirrhosis and portal hypertensionP Calès, H Caillau, O Crambes, et al.
Hepatology (Baltimore, Md.)|June 1, 1991
Systemic and splanchnic hemodynamic effects of molsidomine in rats with carbon tetrachloride-induced cirrhosisH Desmorat, J P Vinel, O Lahlou, et al.
Gastroenterology|May 1, 1992
Propranolol reduces the rebleeding rate during endoscopic sclerotherapy before variceal obliterationJ P Vinel, H Lamouliatte, P Cales, et al.
Gastroenterologie Clinique Et Biologique|June 1, 1987
[Primary biliary cirrhosis associated with autoimmune thrombopenic purpura and pleuropericarditis]P Calès, J P Vinel, J J Voigt, et al.
Gastroenterologie Clinique Et Biologique|June 29, 1999
[Treatment by porto-systemic intrahepatic shunt for refractory hydrothorax during cirrhosis]J M Péron, E Dupuis, L Alric, et al.
Hepatology (Baltimore, Md.)|October 26, 1999
Transjugular intrahepatic portosystemic shunt in the treatment of refractory bleeding from ruptured gastric varicesK Barange, J M Péron, K Imani, et al.
Gut|April 1, 1993
Diffuse vascular ectasia of the antrum, duodenum, and jejunum in a patient with nodular regenerative hyperplasia. Lack of response to portosystemic shunt or gastrectomyP Calès, J J Voigt, J L Payen, et al.
Journal of Medical Virology|March 13, 1998
Baseline level and early suppression of serum HCV RNA for predicting sustained complete response to alpha-interferon therapyJ Izopet, J L Payen, L Alric, et al.
Tissue Antigens|October 6, 2000
Study of host- and virus-related factors associated with spontaneous hepatitis C virus clearanceL Alric, M Fort, J Izopet, et al.
Pageof 11